• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . CMTM8 variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/polymorphonuclear myeloid-derived suppres

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Jan 23:17:1717058.
doi: 10.3389/fimmu.2026.1717058. eCollection 2026.
CMTM8 variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/polymorphonuclear myeloid-derived suppressor cell activity

Alessandro Testori[SUP] 1 [/SUP], Antonella Mulas[SUP] 2 [/SUP], Mara Marongiu[SUP] 2 [/SUP], Valeria Orrù[SUP] 2 [/SUP], Monia Lobina[SUP] 2 [/SUP], Maria Grazia Piras[SUP] 2 [/SUP], Erika Lutzu[SUP] 2 [/SUP], Nicolò Curreli[SUP] 2 [/SUP], Cristina Politi[SUP] 3 [/SUP], Marco Mobrici[SUP] 3 [/SUP], Giorgio Iervasi[SUP] 4 [/SUP], Daniela Corda[SUP] 5 [/SUP], Mario De Felice[SUP] 5 [/SUP], Alessandra Testa[SUP] 3 [/SUP], Marcella Devoto[SUP] 1 6 [/SUP], Maristella Steri[SUP] #[/SUP][SUP] 1 [/SUP], Edoardo Fiorillo[SUP] #[/SUP][SUP] 2 [/SUP]; SerGenCovid-19 Investigators


Affiliations
Abstract

Background: The immunoglobulin level following vaccination against SARS-CoV-2 results from a multifaceted immunological process involving cells and molecules that determine its efficacy and protect us against severe infection outcomes. The observed heterogeneity in the immune response to vaccination is partly attributable to host genetic factors; however, this genetic contribution has only been partially explored.
Methods: To elucidate the mechanisms underlying the antibody response elicited by the Pfizer-BioNTech vaccine, we conducted a genome-wide association study on anti-spike immunoglobulin G levels measured in 1,968 Italian individuals who received two doses of the vaccine, selected from a larger cohort of 7,169 volunteers characterized for 8 million genetic variants. Sex, age, body mass index, smoking habit, and time elapsed between vaccine administration and blood draw were accounted as covariates in the linear regression model.
Results: We identified a novel signal of association on chromosome 3 in the intronic region of the CMTM8 gene and confirmed one previously identified at the HLA locus close to the HLA-B gene. The lead SNP in the CMTM8 gene, rs7643677 (p-value = 2.095×10[SUP]-8[/SUP]), is associated with anti-S IgG levels and with the expression level of CD66b on granulocytic/polymorphonuclear myeloid-derived suppressor cells.
Conclusions: These findings support a role for CMTM8 in regulating the suppressive activity of specific immune cells, and suggest a potential interplay among genetic, humoral, and cellular mechanisms underlying the immune response to SARS-CoV-2 vaccination.

Keywords: BNT162b2; CMTM8; GWAS; HLA; MDSC (myeloid-derived suppressor cells).

 
Back
Top Bottom